Crystal Woodard, Ph.D.
About Crystal Woodard, Ph.D.
Crystal Woodard, Ph.D., serves as a Medical Science Liaison at Bristol-Myers Squibb, covering the Southeast U.S. territory. She holds a Ph.D. in Pharmacology and Molecular Sciences from Johns Hopkins University and a B.S. in Chemistry from Hampton University.
Education at The Johns Hopkins University School of Medicine
Crystal Woodard, Ph.D., pursued her advanced studies at The Johns Hopkins University School of Medicine, where she specialized in Pharmacology and Molecular Sciences. She obtained her Doctor of Philosophy (Ph.D.) from the institution between 2005 and 2011. Her education provided her with a robust foundation in the scientific principles and research methodologies necessary for her career in medical science.
Education at Hampton University
Crystal Woodard earned her Bachelor of Science (B.S.) degree in Chemistry from Hampton University. Her undergraduate studies, conducted from 2001 to 2005, laid the groundwork for her scientific expertise. The comprehensive chemistry curriculum at Hampton University equipped her with essential analytical skills and a solid understanding of chemical principles.
Medical Science Liaison at Bristol-Myers Squibb
Crystal Woodard currently serves as a Medical Science Liaison at Bristol-Myers Squibb, focusing on the Southeast U.S. territory, including Georgia and Florida. In her role, she leverages her scientific expertise to foster strategic partnerships, influence key cross-functional stakeholders, and address current disease and product-related needs through compliant discussions.
Expertise in Therapeutic Areas
Crystal Woodard has demonstrated substantial expertise in various therapeutic areas such as immunology, cardiometabolic disorders, oncology, virology, neurology, and pharmacology. Her broad and diverse knowledge base allows her to contribute effectively to interdisciplinary teams and address a wide range of medical and scientific challenges.
Skills in Drug Development and Regulatory Requirements
Crystal Woodard is proficient in understanding drug development processes and possesses working knowledge of good clinical practice (GCP) and regulatory (ICH) requirements. Her skills in these areas ensure that she can navigate complex regulatory landscapes and contribute to the development of safe and effective medical treatments.